Element Biosciences Partners with Dovetail Genomics to Validate its Proximity Ligation-Based NGS Library Prep Solutions for Epigenetics on Element’s AVITI™ System

On February 24, 2022 Element Biosciences, Inc., developer of a new and disruptive DNA sequencing platform, reported a partnership with Dovetail Genomics demonstrating the value and performance of Dovetail’s proximity ligation-based next-generation sequencing (NGS) library prep solutions on Element’s AVITI System (Press release, Element Biosciences, FEB 24, 2022, View Source [SID1234609009]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The ability to unlock access to genomic structure enables cutting-edge science in the fields of epigenetics, developmental biology, cancer research, conservation and evolutionary biology. Advances in chromatin conformation capture technologies sit at the forefront of this effort. Dovetail Genomics’ best-in-class products and services capture 3D genome architecture alongside primary sequence information using NGS approaches.

"We are pleased to form a partnership with Dovetail Genomics to deliver seamless compatibility between the AVITI System and Dovetail’s library preparation kits. Their proximity ligation technology couples well with Element’s improvements in sequencing accuracy, lower optical duplication rate and consistency of data, across a range of applications," said Shawn Levy, Senior Vice President of Applications and Scientific Affairs at Element Biosciences.

"We are thrilled to partner with Element Biosciences to add Dovetail Genomics’ cutting-edge proximity ligation technology to this new and exciting NGS platform," said Dovetail CEO Todd Dickinson. "The long-range, unbiased nature of the Dovetail data opens up many new applications not typically accessible with a short-read platform, offering a richer view of the genome from every sequencing run."

To learn more about the AVITI System, including detailed specifications, application data, and performance testimonials, register now for Element’s virtual event on March 14th, 9 a.m. PT / 5 p.m. CET, at View Source